Report cover image

Adult and Pediatric Vaccines Industry Research Report 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 122 Pages
SKU # APRC20543980

Description

Summary

According to APO Research, The global Adult and Pediatric Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Adult and Pediatric Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Adult and Pediatric Vaccines include Sanofi, Johnson and Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Sinovac Biotech, AstraZeneca and Takeda Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Adult and Pediatric Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult and Pediatric Vaccines.The Adult and Pediatric Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult and Pediatric Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Adult and Pediatric Vaccines Segment by Company
Sanofi Johnson and Johnson Novartis Merck Pfizer GlaxoSmithKline Sinovac Biotech AstraZeneca Takeda Pharmaceutical LG Life Sciences Bavarian NordicAdult and Pediatric Vaccines Segment by Type
Adult Vaccines Pediatric VaccinesAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Application
Hospitals Medical Care Centers OthersAdult and Pediatric Vaccines Segment by Region
North America United States Canada Mexico Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia Taiwan Southeast Asia South America Brazil Argentina Chile Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt

Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Adult and Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Adult and Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Adult and Pediatric Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Adult and Pediatric Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Table of Contents

122 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Adult and Pediatric Vaccines by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Adult Vaccines
2.2.3 Pediatric Vaccines
2.3 Adult and Pediatric Vaccines by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospitals
2.3.3 Medical Care Centers
2.3.4 Others
2.4 Assumptions and Limitations
3 Adult and Pediatric Vaccines Breakdown Data by Type
3.1 Global Adult and Pediatric Vaccines Historic Market Size by Type (2020-2025)
3.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031)
4 Adult and Pediatric Vaccines Breakdown Data by Application
4.1 Global Adult and Pediatric Vaccines Historic Market Size by Application (2020-2025)
4.2 Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Adult and Pediatric Vaccines Market Perspective (2020-2031)
5.2 Global Adult and Pediatric Vaccines Growth Trends by Region
5.2.1 Global Adult and Pediatric Vaccines Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Adult and Pediatric Vaccines Historic Market Size by Region (2020-2025)
5.2.3 Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031)
5.3 Adult and Pediatric Vaccines Market Dynamics
5.3.1 Adult and Pediatric Vaccines Industry Trends
5.3.2 Adult and Pediatric Vaccines Market Drivers
5.3.3 Adult and Pediatric Vaccines Market Challenges
5.3.4 Adult and Pediatric Vaccines Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Adult and Pediatric Vaccines Players by Revenue
6.1.1 Global Top Adult and Pediatric Vaccines Players by Revenue (2020-2025)
6.1.2 Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)
6.2 Global Adult and Pediatric Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Adult and Pediatric Vaccines Head Office and Area Served
6.4 Global Adult and Pediatric Vaccines Players, Product Type & Application
6.5 Global Adult and Pediatric Vaccines Manufacturers Established Date
6.6 Global Adult and Pediatric Vaccines Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Adult and Pediatric Vaccines Market Size (2020-2031)
7.2 North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
7.4 North America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Adult and Pediatric Vaccines Market Size (2020-2031)
8.2 Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025)
8.4 Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Adult and Pediatric Vaccines Market Size (2020-2031)
9.2 Asia-Pacific Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2020-2025)
9.4 Asia-Pacific Adult and Pediatric Vaccines Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Adult and Pediatric Vaccines Market Size (2020-2031)
10.2 South America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Adult and Pediatric Vaccines Market Size by Country (2020-2025)
10.4 South America Adult and Pediatric Vaccines Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Adult and Pediatric Vaccines Market Size (2020-2031)
11.2 Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025)
11.4 Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.1.4 Sanofi Adult and Pediatric Vaccines Product Portfolio
12.1.5 Sanofi Recent Developments
12.2 Johnson and Johnson
12.2.1 Johnson and Johnson Company Information
12.2.2 Johnson and Johnson Business Overview
12.2.3 Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.2.4 Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
12.2.5 Johnson and Johnson Recent Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.3.4 Novartis Adult and Pediatric Vaccines Product Portfolio
12.3.5 Novartis Recent Developments
12.4 Merck
12.4.1 Merck Company Information
12.4.2 Merck Business Overview
12.4.3 Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.4.4 Merck Adult and Pediatric Vaccines Product Portfolio
12.4.5 Merck Recent Developments
12.5 Pfizer
12.5.1 Pfizer Company Information
12.5.2 Pfizer Business Overview
12.5.3 Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.5.4 Pfizer Adult and Pediatric Vaccines Product Portfolio
12.5.5 Pfizer Recent Developments
12.6 GlaxoSmithKline
12.6.1 GlaxoSmithKline Company Information
12.6.2 GlaxoSmithKline Business Overview
12.6.3 GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.6.4 GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
12.6.5 GlaxoSmithKline Recent Developments
12.7 Sinovac Biotech
12.7.1 Sinovac Biotech Company Information
12.7.2 Sinovac Biotech Business Overview
12.7.3 Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.7.4 Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
12.7.5 Sinovac Biotech Recent Developments
12.8 AstraZeneca
12.8.1 AstraZeneca Company Information
12.8.2 AstraZeneca Business Overview
12.8.3 AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.8.4 AstraZeneca Adult and Pediatric Vaccines Product Portfolio
12.8.5 AstraZeneca Recent Developments
12.9 Takeda Pharmaceutical
12.9.1 Takeda Pharmaceutical Company Information
12.9.2 Takeda Pharmaceutical Business Overview
12.9.3 Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.9.4 Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
12.9.5 Takeda Pharmaceutical Recent Developments
12.10 LG Life Sciences
12.10.1 LG Life Sciences Company Information
12.10.2 LG Life Sciences Business Overview
12.10.3 LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.10.4 LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
12.10.5 LG Life Sciences Recent Developments
12.11 Bavarian Nordic
12.11.1 Bavarian Nordic Company Information
12.11.2 Bavarian Nordic Business Overview
12.11.3 Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025)
12.11.4 Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
12.11.5 Bavarian Nordic Recent Developments
13 Report Conclusion
14 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Adult and Pediatric Vaccines Market Size by Type (2020-2025) & (US$ Million)
Table 6. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2020-2025)
Table 7. Global Adult and Pediatric Vaccines Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 8. Global Adult and Pediatric Vaccines Revenue Market Share by Type (2026-2031)
Table 9. Global Adult and Pediatric Vaccines Market Size by Application (2020-2025) & (US$ Million)
Table 10. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2020-2025)
Table 11. Global Adult and Pediatric Vaccines Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 12. Global Adult and Pediatric Vaccines Revenue Market Share by Application (2026-2031)
Table 13. Global Adult and Pediatric Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 14. Global Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 15. Global Adult and Pediatric Vaccines Market Share by Region (2020-2025)
Table 16. Global Adult and Pediatric Vaccines Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 17. Global Adult and Pediatric Vaccines Market Share by Region (2026-2031)
Table 18. Adult and Pediatric Vaccines Industry Trends
Table 19. Adult and Pediatric Vaccines Industry Drivers
Table 20. Adult and Pediatric Vaccines Industry Opportunities and Challenges
Table 21. Adult and Pediatric Vaccines Market Restraints
Table 22. Global Top Adult and Pediatric Vaccines Players by Revenue (US$ Million) & (2020-2025)
Table 23. Global Adult and Pediatric Vaccines Revenue Market Share by Players (2020-2025)
Table 24. Global Adult and Pediatric Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
Table 25. Global Key Players of Adult and Pediatric Vaccines, Headquarters and Area Served
Table 26. Global Adult and Pediatric Vaccines Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Adult and Pediatric Vaccines by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. North America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 32. North America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 33. Europe Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 34. Europe Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 35. Europe Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Adult and Pediatric Vaccines Market Size by Region (2020-2025) & (US$ Million)
Table 38. Asia Pacific Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 39. South America Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 40. South America Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 41. South America Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 42. Middle East & Africa Adult and Pediatric Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Adult and Pediatric Vaccines Market Size by Country (2026-2031) & (US$ Million)
Table 45. Sanofi Company Information
Table 46. Sanofi Business Overview
Table 47. Sanofi Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 48. Sanofi Adult and Pediatric Vaccines Product Portfolio
Table 49. Sanofi Recent Developments
Table 50. Johnson and Johnson Company Information
Table 51. Johnson and Johnson Business Overview
Table 52. Johnson and Johnson Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 53. Johnson and Johnson Adult and Pediatric Vaccines Product Portfolio
Table 54. Johnson and Johnson Recent Developments
Table 55. Novartis Company Information
Table 56. Novartis Business Overview
Table 57. Novartis Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 58. Novartis Adult and Pediatric Vaccines Product Portfolio
Table 59. Novartis Recent Developments
Table 60. Merck Company Information
Table 61. Merck Business Overview
Table 62. Merck Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 63. Merck Adult and Pediatric Vaccines Product Portfolio
Table 64. Merck Recent Developments
Table 65. Pfizer Company Information
Table 66. Pfizer Business Overview
Table 67. Pfizer Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 68. Pfizer Adult and Pediatric Vaccines Product Portfolio
Table 69. Pfizer Recent Developments
Table 70. GlaxoSmithKline Company Information
Table 71. GlaxoSmithKline Business Overview
Table 72. GlaxoSmithKline Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 73. GlaxoSmithKline Adult and Pediatric Vaccines Product Portfolio
Table 74. GlaxoSmithKline Recent Developments
Table 75. Sinovac Biotech Company Information
Table 76. Sinovac Biotech Business Overview
Table 77. Sinovac Biotech Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 78. Sinovac Biotech Adult and Pediatric Vaccines Product Portfolio
Table 79. Sinovac Biotech Recent Developments
Table 80. AstraZeneca Company Information
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 83. AstraZeneca Adult and Pediatric Vaccines Product Portfolio
Table 84. AstraZeneca Recent Developments
Table 85. Takeda Pharmaceutical Company Information
Table 86. Takeda Pharmaceutical Business Overview
Table 87. Takeda Pharmaceutical Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 88. Takeda Pharmaceutical Adult and Pediatric Vaccines Product Portfolio
Table 89. Takeda Pharmaceutical Recent Developments
Table 90. LG Life Sciences Company Information
Table 91. LG Life Sciences Business Overview
Table 92. LG Life Sciences Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 93. LG Life Sciences Adult and Pediatric Vaccines Product Portfolio
Table 94. LG Life Sciences Recent Developments
Table 95. Bavarian Nordic Company Information
Table 96. Bavarian Nordic Business Overview
Table 97. Bavarian Nordic Revenue in Adult and Pediatric Vaccines Business (2020-2025) & (US$ Million)
Table 98. Bavarian Nordic Adult and Pediatric Vaccines Product Portfolio
Table 99. Bavarian Nordic Recent Developments
Table 100. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Adult and Pediatric Vaccines Product Image
Figure 5. Global Adult and Pediatric Vaccines Market Size Comparison by Type (2025-2031) & (US$ Million)
Figure 6. Global Adult and Pediatric Vaccines Market Share by Type: 2024 VS 2031
Figure 7. Adult Vaccines Product
Figure 8. Pediatric Vaccines Product
Figure 9. Global Adult and Pediatric Vaccines Market Size by Application (2025-2031) & (US$ Million)
Figure 10. Global Adult and Pediatric Vaccines Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Product
Figure 12. Medical Care Centers Product
Figure 13. Others Product
Figure 14. Global Adult and Pediatric Vaccines Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Adult and Pediatric Vaccines Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Adult and Pediatric Vaccines Market Share by Region: 2024 VS 2031
Figure 17. Global Adult and Pediatric Vaccines Market Share by Players in 2024
Figure 18. Global Adult and Pediatric Vaccines Manufacturers Established Date
Figure 19. Global Top 5 and 10 Adult and Pediatric Vaccines Players Market Share by Revenue in 2024
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. North America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 23. United States Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Mexico Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 26. Europe Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 28. Germany Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Spain Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Netherlands Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 38. China Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 43. Australia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. China Taiwan Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. South America Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. South America Adult and Pediatric Vaccines Market Share by Country (2020-2031)
Figure 48. Brazil Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Argentina Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Chile Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Colombia Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Peru Adult and Pediatric Vaccines Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Sanofi Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 54. Johnson and Johnson Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 55. Novartis Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 56. Merck Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 57. Pfizer Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 59. Sinovac Biotech Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 60. AstraZeneca Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 61. Takeda Pharmaceutical Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 62. LG Life Sciences Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
Figure 63. Bavarian Nordic Revenue Growth Rate in Adult and Pediatric Vaccines Business (2020-2025)
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.